Relmada Therapeutics (RLMD) Stock Price Today, Chart, Quote and News | baraka

R

Relmada Therapeutics (RLMD)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Relmada Therapeutics (RLMD)

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on developing treatments for central nervous system (CNS) disorders. Its product candidate includes dextromethadone (d-methadone), REL-1017, REL-1015 (LevoCa... Read more

Open
USD3.69
High
USD3.87
Low
USD3.62
52 Week High
USD7.22
Monthly Return
-24.50%
Revenue
--

Daily Vol.
80.01k
Avg. Daily Vol.
119.43k
Market Cap.
121M
52 Week Low
2.36
Annual Return
47.40%

Stock News

High Risk, Low Reward For These REITs With Massive 13%+ Yields

High Risk, Low Reward For These REITs With Massive 13%+ Yields

Yahoo

GrafTech International (EAF) Q1 2024 Earnings Call Transcript

Yahoo

Oxford Square Capital Corp. Schedules First Quarter 2024 Earnings Release and Conference Call for May 2, 2024

Oxford Square Capital Corp. Schedules First Quarter 2024 Earnings Release and Conference Call for May 2, 2024

Yahoo

Chip Gear Vendor KLA Tops March-Quarter Views As Business Stabilizes

Chip Gear Vendor KLA Tops March-Quarter Views As Business Stabilizes

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.